Actively Recruiting
Panniculitis in Dermatomyositis
Led by University Hospital, Strasbourg, France · Updated on 2026-01-16
20
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adipose tissue involvement is rare in dermatomyositis. The occurrence of partial or diffuse lipodystrophy is a rare but well-characterized manifestation, particularly in juvenile forms of dermatomyositis. Panniculitis, on the other hand, is exceptional and rarely described in the literature, mostly in the form of clinical cases. Panniculitis in dermatomyositis is exceptional. There are no validated diagnostic criteria or treatment recommendations. Treatment is based, by analogy, on the therapeutic strategy for lupus panniculitis and involves synthetic antimalarials combined with steroids and/or immunosuppressants. The aim of this study is to describe panniculitis in dermatomyositis in order to determine whether there are clinical or histological characteristics that distinguish it from other causes of panniculitis, particularly panniculitis associated with lupus erythematosus.
CONDITIONS
Official Title
Panniculitis in Dermatomyositis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject aged 1 year and older
- Confirmed diagnosis of dermatomyositis
- Confirmed diagnosis of panniculitis
You will not qualify if you...
- Panniculitis caused by another confirmed reason, especially infectious or metabolic causes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de dermatologie - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
D
Dan LIPSKER, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here